Bloomberg Businessweek found investors racing to pour money into peptides ahead of legalization, pegging the gray market at one to three billion dollars, even as the panel being asked to open the door has historically wanted the kind of large-scale human trials BPC-157 has never had
The Math Isnt Simple, December 2024 19 The Economist, GLP-1s like Ozempic are among the most important drug breakthroughs ever, October 2024 20 The Intake, 26% plan to include GLP-1 meds in 2025 goals, led by 37% of Gen Z, December 2024 RO4166622-0125 The content contained in this blog post is intended for general informational purposes only and is not meant to constitute legal, tax, accounting or investment advice
Successful weight loss can lead to improvements in overall health, such as reduced risk of chronic diseases like type 2 diabetes, cardiovascular disease, and certain types of cancer
The GIP receptor activation may specifically influence how the body handles fat storage and mobilization, providing a metabolic advantage beyond simple caloric restriction